Theratechnologies Inc. (TSE:TH) traded up 1.1% during mid-day trading on Monday . The company traded as high as C$6.64 and last traded at C$6.43. 123,094 shares changed hands during mid-day trading, a decline of 21% from the average session volume of 155,844 shares. The stock had previously closed at C$6.50.
A number of research analysts have recently weighed in on the stock. Scotiabank reduced their target price on shares of Theratechnologies from C$10.00 to C$9.25 and set an “outperform” rating for the company in a research report on Friday, October 6th. National Bank Financial increased their target price on shares of Theratechnologies from C$9.25 to C$9.75 and gave the company an “outperform” rating in a research report on Thursday, October 5th.
Theratechnologies Company Profile
Theratechnologies Inc is a specialty pharmaceutical company. The Company addresses medical needs to promote healthy living among human immunodeficiency virus (HIV) patients. Its products include EGRIFTA and Ibalizumab. EGRIFTA (tesamorelin for injection) refers to tesamorelin and it is indicated for the reduction of excess abdominal fat in HIV infected patients with lipodystrophy.
Receive News & Ratings for Theratechnologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.